Diagnostic value of the colchicine therapeutic trial
- 20 February 1967
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 199 (8) , 525-528
- https://doi.org/10.1001/jama.199.8.525
Abstract
The reliability of the colchicine therapeutic trial as a diagnostic tool in differentiating acute gout from other forms of arthritis was tested in this study. Rigid criteria for improvement as a result of colchicine therapy were established: major subsidence of objective joint inflammatory changes within 48 hours of colchicine therapy, and no recrudescence of inflammatory joint manifestations within seven days. Approximately 75% (44 of 58) of patients with acute gout responded in this manner; three of 62 (5%) patients with other arthritic disorders also responded. It is concluded that the colchicine therapeutic trial is a useful, but not infallible, diagnostic aid.This publication has 2 references indexed in Scilit:
- The Syndrome of Sarcoidosis, Psoriasis, and GoutAnnals of Internal Medicine, 1962
- A DISCUSSION OF A THERAPEUTIC TEST AND A PROVOCATIVE TEST IN GOUTY ARTHRITISAnnals of Internal Medicine, 1939